Mohammad Shadid
Impact in
- Sensory Systems top 5%
- Ion Channels and Receptors
-
- Ionic liquids properties and applications
Papers in
-
- Cancer therapeutics and mechanisms 2
- Metabolomics and Mass Spectrometry Studies 2
- CRISPR and Genetic Engineering 2
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
- Oncology 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Garold S. Yost (2 shared papers)Christopher A. Reilly (1 shared paper)Abedelnasser Abulrob (1 shared paper)Mohamed Badawi (1 shared paper)Jayaprakasam Bolleddula (3 shared papers)Ian M. Romaine (1 shared paper)Neil Osheroff (1 shared paper)Clemens Anklin (1 shared paper)
- Journals
- Drug Metabolism and Disposition (2 papers)Pharmaceutical Research (1 paper)MedChemComm (1 paper)Expert Opinion on Drug Metabolism & Toxicology (1 paper)Bioorganic & Medicinal Chemistry (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Mohammad Shadid
12 papers receiving 345 citations
Peers
Comparison fields: 5 of 72
- Sensory Systems 76
- Catalysis 36
- Toxicology 12
- Pharmaceutical Science 18
- Molecular Biology 180
Countries citing papers authored by Mohammad Shadid
This map shows the geographic impact of Mohammad Shadid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Shadid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Shadid more than expected).
Fields of papers citing papers by Mohammad Shadid
This network shows the impact of papers produced by Mohammad Shadid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Shadid. The network helps show where Mohammad Shadid may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Shadid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 98 | |
| 2 | 2021 | 65 | |
| 3 | 2015 | 54 | |
| 4 | 2008 | 46 | |
| 5 | 2017 | 20 | |
| 6 | 2009 | 18 | |
| 7 | 2005 | 16 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 10 | |
| 10 | 2016 | 8 | |
| 11 | 2024 | 2 | |
| 12 | 2018 | 2 | |
| 13 | 2025 | 0 |
About Mohammad Shadid
Mohammad Shadid is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Infectious Diseases, having authored 13 papers that have together received 349 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (2 papers), Virus-based gene therapy research (2 papers), HER2/EGFR in Cancer Research (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), CRISPR and Genetic Engineering (2 papers), RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Sensory Systems (76 citations), Catalysis (36 citations), Toxicology (12 citations), Pharmaceutical Science (18 citations) and Molecular Biology (180 citations). Mohammad Shadid has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Garold S. Yost, Christopher A. Reilly, Abedelnasser Abulrob, Mohamed Badawi, Jayaprakasam Bolleddula, Ian M. Romaine, Neil Osheroff, Clemens Anklin, Ryan Bender and David E. Graves. Their work appears in journals such as Drug Metabolism and Disposition, Pharmaceutical Research, MedChemComm, Expert Opinion on Drug Metabolism & Toxicology and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.